Healthcare company Omega Healthcare Investors Inc (NYSE:OHI) stated on Tuesday its net income of USD72.2m (USD0.34 per common share) for the quarter ended 31 March 2019.
This marks a decrease in earnings when compared with net income of USD87.9m (USD0.42 per common share) for the corresponding period in 2018.
The company added the decline in net income for the quarter ended 31 March 2019 versus the prior year was primarily due to the reduction in gains on the sale of assets, an increase of costs related to the acquisition of MedEquities Realty Trust as well as an increase of of impairments
Operating revenues of USD223.7m were generated for the quarter ended 31 March 2019, up over operating revenues of USD220.2m for the same period in 2018.
Acerus and Aytu Bioscience to Co-promote Natesto in the United States
Amgen reports financial results for Q2 2019
Pfizer to integrate Upjohn with Mylan to establish new global pharmaceutical company
Neurocrine Biosciences reports half-year ended 30 June 2019 financial results
Thermo Fisher Scientific reports financial results for Q2 2019
Veloxis Pharmaceuticals revises 2019 outlook
NANOBIOTIX collects revenues of EUR31.9,000 for Q2 2019
Seattle Genetics incurs net loss of USD79.2m in Q2 2019
Baxter's board announces USD0.22 per share dividend pay order
Johnson & Johnson declares dividend of USD0.95 per share for Q3 2019
Sun Pharma Launches Ezallor Sprinkle in the US for People Who Have Difficulty Swallowing
PanTheryx Aims to End Diarrheal Disease in Cambodia
CCA Industries Inc swings to income of USD349,320 for Q2 2019
Oncimmune Holdings signs commercial collaboration with R-Pharm JSC